Gliknik Inc
4 private offerings reported to the SEC on Form D since 2016, $33.8M sold in all. Biotech, Maryland.
- Form D offerings: 4
- Reported sold: $33.8M
- Newest: Aug 21, 2025
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Aug 21, 2025 | — | $15.0M | $15.0M | Gliknik IncBiotech · Maryland | Sep 17, 2026 | 0001411569-25-000002 |
| Nov 21, 2024 | — | $5.3M | $6.0M | Gliknik IncBiotech · Maryland | Jan 24, 2025 | 0001411569-24-000002 |
| Jul 7, 2023 | — | $9.2M | $16.2M | Gliknik IncBiotech · Maryland | Mar 21, 2024 | 0001411569-23-000001 |
| Jun 2, 2021 | — | $4.3M | $12.0M | Gliknik IncBiotech · Maryland | Not amended | 0001411569-21-000001 |
- Business address
- Baltimore, MD
- Incorporated in
- Delaware
- All SEC filings
- CIK 1411569 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR